Skip to main content
. Author manuscript; available in PMC: 2017 Feb 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2015 Dec 16;25(2):359–365. doi: 10.1158/1055-9965.EPI-15-0838

Table 1.

Characteristics of cases and controls

Cases Controls
N (%) N (%)
Age (years)
 20–34 182 (24.3) 125 (30.9)
 35–39 285 (38.0) 142 (35.1)
 40–44 128 (17.1) 77 (19.0)
 45–49 155 (20.7) 61 (15.1)
Any first-degree relative with breast cancer
 No 661 (88.1) 379 (93.6)
 Yes 89 (11.9) 26 (6.4)
Age at menarche (years)
 <12 148 (19.7) 66 (16.3)
 12 148 (19.7) 98 (24.2)
 13 231 (30.8) 113 (27.9)
 ≥14 218 (29.1) 128 (31.6)
 Missing 5 (0.7) 0 (0.0)
Age at first live birth (years)
 <20 50 (6.7) 31 (7.7)
 20–24 162 (21.6) 86 (21.2)
 25–29 225 (30.0) 109 (26.9)
 ≥30 128 (17.1) 64 (15.8)
 No live birth 185 (24.7) 115 (28.4)
Estrogen receptor status
 Negative 155 (20.7)
 Positive 261 (34.8)
 Missing 334 (44.5)
Progesterone receptor status
 Negative 118 (15.7)
 Positive 298 (39.7)
 Missing 334 (44.5)